Forcefield Therapeutics

Forcefield Therapeutics Ltd (Forcefield-Tx) is a pioneer in first-class therapies that preserve cardiac function by protecting cardiomyocytes. Founded by scientists, industry experts, and investors with the shared goal of revolutionizing treatment following acute myocardial infarction (AMI), Forcefield Tx adopts a unique approach to retain and safeguard cardiac cells, minimize the impact of AMI, and prevent a cascade of events that could lead to subsequent heart failure. Forcefield Tx is led by a proven team with a successful track record from discovery to commercialization.